K843660

Substantially Equivalent

IN FLUENZA B VIRUS

Applicant: Institute Virion , Ltd.
Product code: GNX
Advisory panel: Microbiology
Date received: 1984-09-17
Decision date: 1985-09-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Oakland, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.